This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.
Also known as: Examorelin
Hexarelin is a synthetic hexapeptide growth hormone secretagogue that produces the most potent GH release of any GHRP. It also has unique GH-independent cardioprotective properties through direct interaction with CD36 receptors on cardiac tissue.
Hexarelin binds GHS-R1a with the highest affinity among peptide secretagogues, producing dose-dependent GH release superior to GHRP-2 and GHRP-6. Unlike other GHRPs, it directly binds CD36 receptors on cardiac tissue, activating ERK1/2 and PI3K signaling for cardiomyocyte protection independent of GH. This dual mechanism makes hexarelin uniquely cardioprotective. Desensitization occurs more rapidly than with ipamorelin, necessitating cycling or rotating protocols.
Hexarelin binds GHS-R1a with the highest affinity among peptide secretagogues, producing dose-dependent GH release superior to GHRP-2 and GHRP-6. Unlike other GHRPs, it directly binds CD36 receptors on cardiac tissue, activating ERK1/2 and PI3K signaling for cardiomyocyte protection independent of GH. This dual mechanism makes hexarelin uniquely cardioprotective. Desensitization occurs more rapidly than with ipamorelin, necessitating cycling or rotating protocols.
Hexarelin is a synthetic hexapeptide growth hormone secretagogue that produces the most potent GH release of any GHRP. It also has unique GH-independent cardioprotective properties through direct interaction with CD36 receptors on cardiac tissue. Research spans GH deficiency treatment, cardiac protection post-ischemia, and body composition optimization.
IUPAC Name
His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH2
CAS Number
140703-51-1
Molecular Formula
C47H58N12O6
Molecular Mass
887.05 g/mol
Create a free account to:
Join 2,800+ researchers
Create a free account to:
Join 2,800+ researchers
Active cancer. Pituitary disorders. Pregnancy or breastfeeding.
Research Disclaimer
This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.
$44.99
$4.4990
1
1
vial
Growth Hormone / IGF-1 Axis
CJC-1295 without DAC (Modified GRF 1-29) is a synthetic 29-amino acid GHRH analog with four amino acid substitutions that extend its half-life from under 2 minutes to approximately 30 minutes.
Growth Hormone / IGF-1 Axis
CJC-1295 with DAC uses a Drug Affinity Complex linker (maleimidopropionic acid) that forms a permanent covalent bond with serum albumin after injection, extending the half-life to 6β8 days.
Growth Hormone / IGF-1 Axis
GHRP-2 is a synthetic hexapeptide growth hormone-releasing peptide that potently stimulates GH release from the pituitary gland.
Growth Hormone / IGF-1 Axis
GHRP-6 is a synthetic hexapeptide growth hormone secretagogue and one of the original GHRPs studied.
Growth Hormone / IGF-1 Axis
IGF-1 LR3 (Long R3 IGF-1) is a modified analog of insulin-like growth factor 1 featuring an arginine substitution at position 3 and a 13-amino acid N-terminal extension.
Growth Hormone / IGF-1 Axis
Ipamorelin is a selective pentapeptide growth hormone secretagogue that mimics ghrelin at the GHSR-1a receptor with high selectivity.
View Full Dosage Guide β
Protocols, calculator & safety for Hexarelin
14 PubMed studies
Data Completeness
100%Research Credibility
Half-Life
~70 minutes
Molecular Weight
887.05 g/mol
Administration
Subcutaneous, Intramuscular
CAS Number
140703-51-1
Trial Phase
Phase 2
Common Side Effects
Stop Use If
Research Disclaimer
This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.
Hexarelin is a synthetic hexapeptide growth hormone secretagogue that produces the most potent GH release of any GHRP. It also has unique GH-independent cardioprotective properties through direct interaction with CD36 receptors on cardiac tissue. Research spans GH deficiency treatment, cardiac protection post-ischemia, and body composition optimization.
Hexarelin is available in vial form.
Prices start at $44.99 across 1 verified vendor.
Compare prices, payment methods, shipping, and COA scores across 1 vendor.
Growth Hormone / IGF-1 Axis
CJC-1295 without DAC (Modified GRF 1-29) is a synthetic 29-amino acid GHRH analog with four amino acid substitutions that extend its half-life from under 2 minutes to approximately 30 minutes.
Growth Hormone / IGF-1 Axis
CJC-1295 with DAC uses a Drug Affinity Complex linker (maleimidopropionic acid) that forms a permanent covalent bond with serum albumin after injection, extending the half-life to 6β8 days.
Growth Hormone / IGF-1 Axis
GHRP-2 is a synthetic hexapeptide growth hormone-releasing peptide that potently stimulates GH release from the pituitary gland.
Growth Hormone / IGF-1 Axis
GHRP-6 is a synthetic hexapeptide growth hormone secretagogue and one of the original GHRPs studied.
Growth Hormone / IGF-1 Axis
IGF-1 LR3 (Long R3 IGF-1) is a modified analog of insulin-like growth factor 1 featuring an arginine substitution at position 3 and a 13-amino acid N-terminal extension.
Growth Hormone / IGF-1 Axis
Ipamorelin is a selective pentapeptide growth hormone secretagogue that mimics ghrelin at the GHSR-1a receptor with high selectivity.